Home
Ra Capital Management reported a 9.9% stake in Inhibikase Therapeutics IKT · 14,653,994 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.9%
- Last report
- 15.9% · filed 26/07/17
- Shares held
- 14,653,994 sh
- Class
- Common Stock, $0.001 par value per share
- Holder
- Ra Capital Management
- Event date
- 26/07/29
- Filed
- 26/07/31
9.9% stake · −6.0pp from the last report
- Stake
- 9.9%
- Last report
- 15.9%
- Since last report
- −6.0pp
Inhibikase Therapeutics trades, last 26 weeks
What else happened in Inhibikase Therapeutics around then
Filed or reported within 30 days of the trade day · 06/29~08/28Ra Capital Management's other 5% stake reports
- Ra Capital Management
5% stakeCorbus Pharmaceuticals Holdings
5% stakeCorbus Pharmaceuticals Holdings
CRBP
9.9% stake
1,914,788 sh
9.9% stake
Filed 09/30
- Ra Capital Management
5% stakeBetterLife Pharma
5% stakeBetterLife Pharma
BETRF
9% stake
55,420,000 sh
9% stake
Filed 09/22
- Ra Capital Management
5% stakeSionna Therapeutics
5% stakeSionna Therapeutics
SION
14.3% stake
6,476,193 sh
14.3% stake
Filed 09/21
- Ra Capital Management
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
19.9% stake
14,130,492 sh
19.9% stake
Filed 09/17
- Ra Capital Management
5% stakeJatt III Acquisition
5% stakeJatt III Acquisition
JTTT
5.1% stake
450,000 sh
5.1% stake
Filed 09/03
